Marko Lehtonen

Marko Lehtonen is a Research Director at the School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland. His work focuses on metabolomics, pharmacokinetics, and analytical chemistry with applications in neuropharmacology, cardiovascular research, and nutritional science.

His research spans multiple domains:

• Metabolomics: Systematic analysis of metabolic profiles in diseases like alcohol-related liver disease, rheumatoid arthritis, and neurodegeneration
• Drug Delivery: Mechanistic studies on LAT1 transporter for brain-targeted therapies and prodrug development
• Dietary Biomarkers: Identification of whole-grain metabolites, obesity-related shifts, and microbiota interactions

Recent publications reveal trends in cross-species metabolite profiling, pregnancy-related biomarkers, and neuroinflammatory pathways. His collaborations span translational medicine (e.g., Parkinson's disease studies) and environmental toxicology (e.g., PCB 180 exposure analysis).